Genetic Analysis of SARS-CoV-2 Variants in Mexico during the First Year of the COVID-19 Pandemic.
SARS-CoV-2
genomic surveillance
viral diversity
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
26 10 2021
26 10 2021
Historique:
received:
20
08
2021
revised:
09
10
2021
accepted:
19
10
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
15
12
2021
Statut:
epublish
Résumé
During the first year of the SARS-CoV-2 pandemic in Mexico, more than two million people were infected. In this study, we analyzed full genome sequences from 27 February 2020 to 28 February 2021 to characterize the geographical and temporal distribution of SARS-CoV-2 lineages and identify the most common circulating lineages during this period. We defined six different geographical regions with particular dynamics of lineage circulation. The Northeast and Northwest regions were the ones that exhibited the highest lineage diversity, while the Central south and South/Southeast regions presented less diversity with predominance of a certain lineage. Additionally, by late February 2021, lineage B.1.1.519 represented more than 89% of all circulating lineages in the country.
Identifiants
pubmed: 34834967
pii: v13112161
doi: 10.3390/v13112161
pmc: PMC8622467
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Emerg Infect Dis. 2021 Feb;27(2):612-615
pubmed: 33496228
Cell. 2021 Jun 24;184(13):3426-3437.e8
pubmed: 33991487
Cell. 2021 Jan 7;184(1):64-75.e11
pubmed: 33275900
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Syst Biol. 2016 Jan;65(1):82-97
pubmed: 26424727
Rev Invest Clin. 2020;72(3):151-158
pubmed: 32584330
Cell Host Microbe. 2021 Dec 8;29(12):1788-1801.e6
pubmed: 34822776
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Cell. 2021 Aug 5;184(16):4220-4236.e13
pubmed: 34242578
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7504-7509
pubmed: 32170017
Viruses. 2021 Aug 26;13(9):
pubmed: 34578275
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Nat Commun. 2021 Jan 19;12(1):434
pubmed: 33469026
J Virol. 2020 Aug 31;94(18):
pubmed: 32641486
Nature. 2021 Feb;590(7844):140-145
pubmed: 33137809
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4
pubmed: 33535027
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Arch Virol. 2020 Sep;165(9):2095-2098
pubmed: 32556599
Elife. 2021 Aug 20;10:
pubmed: 34414884
Science. 2021 Feb 12;371(6530):708-712
pubmed: 33419936
Nat Hum Behav. 2021 Jul;5(7):947-953
pubmed: 33972767
Emerg Infect Dis. 2021 May;27(5):1522-1524
pubmed: 33605869
Arch Virol. 2021 Nov;166(11):3173-3177
pubmed: 34448936
Mol Biol Evol. 2020 Feb 1;37(2):599-603
pubmed: 31633786
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750
iScience. 2022 Jan 21;25(1):103589
pubmed: 34909610
Genomics. 2021 Jul;113(4):2158-2170
pubmed: 34004284
Front Microbiol. 2020 Oct 23;11:550674
pubmed: 33193132
Science. 2020 Dec 18;370(6523):1464-1468
pubmed: 33184236
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652